Female Pulmonary Arterial Hypertension is Associated with Decreased Microrna96 Expression

Emma Wallace,Kirsty M. Mair,Long Lü,Yang Xu,Nick Morrell,Andrew H. Baker,Margaret R. MacLean

IF: 24.3

2014-01-01

European Respiratory Journal

Abstract:Introduction Mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene underlie heritable PAH. PAH occurs more frequently in women. MicroRNAs (miRs) are gene regulators involved in vascular processes including proliferation. Aims We investigated miR expression in mice with a BMPR2 R899X mutation. Methods miRNA and mRNA expression by qRTPCR and protein by westerns were determined in human pulmonary arterial smooth muscle cells (hPASMCs). Proliferation was assessed by cell counts. In vivo levels of oestrogen were depleted in female mice using the aromatase inhibitor anastrozole (3mg/kg/day for 2 weeks). All data, n>6. Results Expression of miR96 was decreased from 1±0.09 to 0.09±0.002 (p 1B protein elevated by ∼61% in PASMCs from female PAH patients (not males) vs. Controls and associated with increased serotonin-induced proliferation. Pre-miR-96 transfected in human PASMCs decreased 5HT 1B protein expression by 40%. Depletion of oestrogen caused a ∼77% increased expression of miR96 and an ∼84% decrease in 5HT 1B expression in whole lung. In hPASMCs, 1nM oestrogen decreased miR96 expression by ∼80% and increased 5HT 1B expression 2-fold. Conclusions Oestrogen-induced decreased miR96 expression, leading to derepressed 5HT 1B expression may predispose female PASMCs to proliferation, contributing to the development of PAH.